The man Joseph Abboud (born May 5, 1950) is an American-Lebanese menswear fashion designer and author. He was born in Boston, Massachusetts and graduated from the University of Massachusetts-Boston in 1972.
Abboud then studied at the Sorbonne in Paris, where he grew to love the sophisticated polish of European style.
(The image above shows Joseph Abboub).
Abboud joined Ralph Lauren in 1981, eventually becoming associate director of menswear design.
He launched his own label in 1987. In 1988, JA Apparel was created as a joint venture between Abboud and GFT (Gruppo Finanziario Tessile) USA.
Abboud sold his trademarks and name to JA Apparel for $65 million in 2000.
The company was acquired by private-equity firm J.W. Childs Associates for $73 million in 2004, and Abboud left JA Apparel in 2005.
The designer launched a new line called Jaz in 2007. He also created the Black Brown 1826 line for the Lord & Taylor department store in 2008. The year 2008 also marked the opening of Abboud’s first stores in China.
In 2010, Abboud became the chief creative officer of HMX, owner of the Hart Schaffner Marx and Hickey Freeman brands.
HMX made an offer to buy JA Apparel for $90 million in 2011. In December 2012, he became Chief Creative Director of Men’s Wearhouse.
Abboud’s mother and sister both succumbed to breast cancer. As a result, Abboud has become a breast cancer activist who designed a one-of-a-kind GMC Sierra vehicle to fundraise for a Concept:Cure charity event. He has also participated in many other charity events for breast cancer research.
“GM offered a Joseph Abboud Limited Edition Buick Regal GS and LS from 2001 to 2004, and a Joseph Abboud Limited Edition Buick Rendezvous for 2004 and 2005.
“Abboud was honored as one of five “Men for the Cure” by GQ magazine and General Motors’ Concept:Cure during a breast cancer fund-raiser. Concept:Cure raised $2.6 million for breast cancer organizations.
Abboud stated: “Concept:Cure is a very special program for me. My mother and sister died from breast cancer. It’s a disease we really have to find a cure for. I know I speak for my colleagues when I say (Concept:Cure) is not about a monetary or PR opportunity for us, it’s about doing something really good.”